TLR3 and colon adenocarcinoma: In essence, an empiricist conclusion highlights the clinical relevance in reverting back pro-tumorigenic M2 macrophages back to their pro-inflammatory phenotype, where in stimulation of TLR-3 ligands may provide a novel therapeutic intervention for COAD patients.